- Nusano to Participate in October Investor Conferences
- Nusano Appoints Industry Expert Alexandre Gibim as Chief Operations Officer
- ICR: ‘Search and destroy’ treatment improves quality of life for patients with advanced prostate cancer
- Video Replay: Unlocking the Next $20-30B Market Opportunity in Oncology: Radioisotope Production & Applications
- Nusano to Participate in Isotope and Radiopharmaceutical Conferences
No comments to show.